| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Common Stock | 724K | $1.63M | $2.25 | Mar 7, 2025 | Direct |
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Common Stock | 52.8K | $119K | $2.25 | Mar 6, 2025 | By spouse |
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Common Stock | 52.8K | $119K | $2.25 | Mar 6, 2025 | Indirect |
| Senti Biosciences, Inc. | CEO and Interim PFO and PAO, Director | Stock Option (Right to Buy) | 1.93M | Mar 6, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SNTI | Senti Biosciences, Inc. | Mar 6, 2025 | 2 | $0 | 4 | Mar 10, 2025 | CEO and Interim PFO and PAO, Director |
| SNTI | Senti Biosciences, Inc. | Feb 4, 2025 | 2 | -$18.3K | 4 | Feb 6, 2025 | CEO, Director |
| SNTI | Senti Biosciences, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 2, 2024 | CEO and President, Director |
| SNTI | Senti Biosciences, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 2, 2023 | CEO and President, Director |
| SNTI | Senti Biosciences, Inc.\ | Jun 8, 2022 | 0 | $0 | 3 | Jun 15, 2022 | CEO and President, Director |